MedTrace Logo

A Prospective Study of a Mosaic Embryo Transfer

NCT04472156 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2024-02-29

No results posted yet for this study

Summary

This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).

Conditions

Interventions

PROCEDURE

Transfer of mosaic embryo

Subjects will transfer a mosaic embryo transferred to their uterus

Sponsors & Collaborators

  • Colorado Center for Reproductive Medicine

    lead OTHER

Principal Investigators

  • Mandy Katz-Jaffe, PhD · Fertility Genetics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2026-06-15
Completion
2026-12-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04472156 on ClinicalTrials.gov